|
DLD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.44098099908297E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.10660394578599E-12 |
| Normal-vs-Stage2 |
6.348200E-01 |
| Normal-vs-Stage3 |
2.81419998415799E-10 |
| Normal-vs-Stage4 |
1.62836411021772E-12 |
| Stage1-vs-Stage2 |
2.836600E-03 |
| Stage1-vs-Stage3 |
5.142200E-01 |
| Stage1-vs-Stage4 |
2.122900E-03 |
| Stage2-vs-Stage3 |
1.937650E-03 |
| Stage2-vs-Stage4 |
3.94900000000309E-05 |
| Stage3-vs-Stage4 |
4.943800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.8968828164343E-14 |
| Normal-vs-AfricanAmerican |
1.51432999999646E-05 |
| Normal-vs-Asian |
1.1394999999137E-07 |
| Caucasian-vs-AfricanAmerican |
4.781400E-01 |
| Caucasian-vs-Asian |
8.659200E-01 |
| AfricanAmerican-vs-Asian |
6.007000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.8688053588819E-11 |
| Normal-vs-Female |
4.2260972499264E-11 |
| Male-vs-Female |
1.912170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.25017790459015E-12 |
| Normal-vs-Age(41-60Yrs) |
3.01790037404714E-10 |
| Normal-vs-Age(61-80Yrs) |
3.722000000006E-05 |
| Normal-vs-Age(81-100Yrs) |
4.789800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.301400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.462000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.709200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.260000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.923600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.909800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.042240E-03 |
| Classical-VS-Follicular |
8.08629999999866E-05 |
| Classical-VS-Other |
1.858770E-01 |
| Classical-VS-Normal |
4.23994173104347E-13 |
| Tall-VS-Follicular |
4.31650000187744E-08 |
| Tall-VS-Other |
7.603000E-01 |
| Tall-VS-Normal |
9.99200722162641E-16 |
| Follicular-VS-Other |
3.736900E-03 |
| Follicular-VS-Normal |
1.957760E-01 |
| Other-VS-Normal |
3.33460000001562E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63069999620436E-08 |
| Normal-vs-N1 |
6.66133814775094E-16 |
| N0-vs-N1 |
1.66788999999001E-05 |
|
|
